https://www.jadpro.com/online-first/2024/practical-management-of-adverse-events-associated-with-fgfr-inhibitors-for-cholangiocarcinoma-for-the-advanced-practice-provider/
JADPRO | Practical Management of Adverse Events Associated With FGFR Inhibitors for...
This review provides practical insights for advanced practice providers on the management of these common AEs associated with selective FGFR inhibitors in the...
adverse eventsassociated withfgfr inhibitorspracticalmanagement
https://oncodaily.com/science/rafael-grochot-277238
Rafael Grochot: The safety and activity of FGFR inhibitors in early-phase clinical trials -...
Apr 18, 2025 - Rafael Grochot: The safety and activity of FGFR inhibitors in early-phase clinical trials / American Society of Clinical Oncology, Anja Williams, Antonella
the safetyfgfr inhibitorsearly phaseclinical trialsrafael
https://bioengineer.org/aacr-early-trial-results-show-benefits-of-fgfr-inhibitors-and/
AACR: Early trial results show benefits of FGFR inhibitors and - BIOENGINEER.ORG
trial resultsbenefits offgfr inhibitorsaacrearly
https://www.ics.muni.cz/veda-a-vyzkum/publikace/1318543
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074,...
fgfr inhibitorsactivityfibroblastgrowthfactor
https://lifesciences.tecan.com/scientific-citation/tas-120-overcomes-resistance-to-atp-competitive-fgfr-inhibitors-in-patients-with-fgfr2-fusion-positive-intrahepatic-cholangiocarcinoma?hsLang=en
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2...
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma
fgfr inhibitorstasresistanceatpcompetitive